Paper Details

  1. Home
  2. Paper Details

A controlled trial of 2-month, 3-month, and 12-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 60 months.

Author:

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

The study found that short-course chemotherapy regimens were inadequate for patients with radiologically active pulmonary tuberculosis, leading to higher relapse rates compared to a standard 12-month regimen. Selective chemotherapy, where treatment was initiated only after confirmation of active disease, was more effective in preventing relapses.
Paper Details　
Original Abstract of the Article :
Of 1,019 Chinese patients with radiologically active pulmonary tuberculosis but with sputum negative for acid-fast bacilli on 5 initial microscopic examinations who were studied for 5 yr, 364 (36%) had 1 or more initial sputum cultures positive for Mycobacterium tuberculosis. All 1,019 patients were...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1164/arrd.1984.130.1.23

データ提供：米国国立医学図書館（NLM）

The Quest for Optimal Treatment Regimens for TB

Tuberculosis (TB), like a persistent desert sandstorm, can linger long after the initial infection, posing a significant threat to health. Researchers are constantly searching for effective treatment regimens to combat this disease, like finding the most effective way to control a sandstorm before it wreaks havoc.

This controlled trial examines the effectiveness of different chemotherapy regimens for sputum-smear-negative pulmonary tuberculosis, a challenging form of the disease. The researchers, like meticulous scientists studying a sandstorm's impact on a desert ecosystem, carefully monitored the patients' response to various treatment durations, comparing their outcomes over a five-year period.

Short-Course Regimens: A Risky Oasis

The study found that short-course regimens, while initially promising, led to higher relapse rates compared to the standard 12-month regimen, like finding an oasis that offers temporary relief but lacks the necessary resources for long-term survival. This suggests that a longer, more comprehensive treatment approach is essential for achieving sustained recovery from TB.

Health Implications and Life Applications

This study highlights the importance of adhering to established treatment guidelines for TB, emphasizing the need for a comprehensive and sustained approach to ensure complete recovery from this potentially life-threatening disease. It serves as a reminder that the journey to recovery from TB requires a thorough and dedicated commitment to treatment, just like navigating a treacherous desert requires a reliable guide and a steady supply of essential resources.

Dr.Camel's Conclusion

Treating TB is like navigating a desert with unexpected storms. Short-term solutions may offer temporary respite, but a longer, more comprehensive approach is crucial for enduring the harsh conditions and ensuring a lasting recovery. This study serves as a reminder that patience and persistence are essential when battling this formidable disease.
Date :
  1. Date Completed 1984-08-21
  2. Date Revised 2007-11-15
Further Info :

Pubmed ID

6377997

DOI: Digital Object Identifier

10.1164/arrd.1984.130.1.23

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.